Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
38.68 Up 0.25(0.65%) Jul 11, 4:00PM EDT
Prev Close:38.43
Open:38.35
Bid:38.50 x 100
Ask:38.90 x 100
1y Target Est:82.63
Beta:2.08
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:37.36 - 38.77
52wk Range:36.11 - 93.33
Volume:393,894
Avg Vol (3m):942,456
Market Cap:1.31B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLVSUp 0.65%1.31B
IMMUUp 2.87%298.95M
LRUSF 0.00%53.41M
THLDUp 1.46%248.07M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):95.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.84
Quarterly EPS Est (Jun-14) :-0.95
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback